BioLife Solutions to Participate in Upcoming Investor Conferences in May and June 2025
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (“CGT”) market, today announced the company will be participating in...

